Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn’s disease (ANDANTE I and II) | Gut

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

XML

Inflammatory bowel disease

Original article

Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn’s disease (ANDANTE I and II)

Online download statistics by month:

Online download statistics by month: December 2017 to May 2022

	Abstract	Full	Pdf
Dec 2017	621	648	200
Jan 2018	688	745	223
Feb 2018	256	249	87
Mar 2018	237	234	59
Apr 2018	163	163	42
May 2018	150	149	33
Jun 2018	106	110	35
Jul 2018	111	111	27
Aug 2018	123	123	34
Sep 2018	102	102	19
Oct 2018	116	116	23
Nov 2018	175	175	45
Dec 2018	635	635	154
Jan 2019	421	406	132
Feb 2019	305	302	298
Mar 2019	220	215	92
Apr 2019	184	178	118
May 2019	187	184	174
Jun 2019	181	178	159
Jul 2019	218	209	151
Aug 2019	233	229	116
Sep 2019	212	207	145
Oct 2019	268	257	180
Nov 2019	209	201	114
Dec 2019	141	136	39
Jan 2020	179	171	45
Feb 2020	139	135	30
Mar 2020	219	216	105
Apr 2020	245	240	69
May 2020	172	170	63
Jun 2020	143	142	72
Jul 2020	142	137	41
Aug 2020	133	128	40
Sep 2020	148	145	37
Oct 2020	144	139	34
Nov 2020	172	168	52
Dec 2020	141	133	68
Jan 2021	198	192	55
Feb 2021	124	122	32
Mar 2021	162	156	52
Apr 2021	228	221	62
May 2021	208	200	58
Jun 2021	158	155	47
Jul 2021	105	103	50
Aug 2021	144	137	63
Sep 2021	172	158	52
Oct 2021	161	155	75
Nov 2021	146	143	52
Dec 2021	159	170	42
Jan 2022	150	156	53
Feb 2022	265	261	44
Mar 2022	182	177	60
Apr 2022	137	136	38
May 2022	137	129	41
Total	11075	10957	4231